Taken together, our results suggest that, as the hub gene related to the M2-like macrophage module, VARS1 exerts an immunosuppressive effect on melanoma progression and is a potential predictive biomarker of clinical outcome and immunotherapy response in melanoma, which requires further investigation in prospective studies and larger populations. The gene discussed is VARS1; the disease is melanoma.